Allergen-specific nasal challenge: Response kinetics of clinical and inflammatory events to rechallenge

被引:23
作者
Ciprandi, G
Ricca, V
Landi, M
Passalacqua, G
Bagnasco, M
Canonica, GW
机构
[1] DIMI Genoa Univ, Allergy & Clin Immunol Serv, Dept Internal Med, I-16132 Genoa, Italy
[2] Koelliker Hosp, Turin, Italy
关键词
allergen-specific nasal challenge; rechallenge; inflammation;
D O I
10.1159/000023896
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Allergen-specific nasal challenge is a valid and reliable tool for studying the pathophysiological mechanisms involved in allergic inflammation. Nasal challenge induces an immediate clinical response in allergic subjects and a concomitant appearance of an inflammatory infiltrate. The mucosal inflammation may persist up to 48-72 h after allergen exposure. If the subjects are rechallenged within this period the response is more pronounced: the so-defined priming effect. The aim of the study was to evaluate the effects of the nasal rechallenge, performed at different time intervals: 3 days, 1, 2 and 4 weeks after the first challenge. Forty allergic subjects underwent two nasal challenges: at baseline and after the periods mentioned above (10/group). Symptoms and inflammatory cells (eosinophils and neutrophils recovered by nasal brushing) were assessed. The 3-day-interval group showed a hyperreactive response (priming effect), the 1- and 4-week-interval groups showed a response similar to baseline, and the 2-week-interval group showed a hyporeactive response ('tolerogenic effect'). The last phenomenon may be due to a possible immunologic response similar to that achievable during local specific immunotherapy. The present results further elucidate the kinetics of allergen-driven inflammatory events and highlight the importance of the time period chosen for rechallenge. The latter fact may be of primary importance in clinical trials involving specific challenge.
引用
收藏
页码:157 / 161
页数:5
相关论文
共 12 条
[1]   A POSSIBLE ROLE FOR ADHESION MOLECULES IN ASTHMA [J].
CALDERON, E ;
LOCKEY, RF .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 90 (05) :852-865
[2]   ALLERGEN-SPECIFIC CHALLENGE INDUCES INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1 OR CD54) ON NASAL EPITHELIAL-CELLS IN ALLERGIC SUBJECTS - RELATIONSHIPS WITH EARLY AND LATE INFLAMMATORY PHENOMENA [J].
CIPRANDI, G ;
PRONZATO, C ;
RICCA, V ;
PASSALACQUA, G ;
BAGNASCO, M ;
CANONICA, GW .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (06) :1653-1659
[3]   EVIDENCE OF INTERCELLULAR-ADHESION MOLECULE-1 EXPRESSION ON NASAL EPITHELIAL-CELLS IN ACUTE RHINOCONJUNCTIVITIS CAUSED BY POLLEN EXPOSURE [J].
CIPRANDI, G ;
PRONZATO, C ;
RICCA, V ;
BAGNASCO, M ;
CANONICA, GW .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 94 (04) :738-746
[4]   THE EFFECT OF FLUTICASONE PROPIONATE AQUEOUS NASAL SPRAY ON NASAL MUCOSAL INFLAMMATION IN PERENNIAL ALLERGIC RHINITIS [J].
GODTHELP, T ;
HOLM, AF ;
BLOM, H ;
KLEINJAN, A ;
RIJNTJES, E ;
FOKKENS, WJ .
ALLERGY, 1995, 50 (23) :21-24
[5]   THE CELLULAR BASIS FOR ALLERGIC RHINITIS [J].
HOWARTH, PH .
ALLERGY, 1995, 50 (23) :6-10
[6]   GLUCOCORTICOSTEROIDS AND RHINITIS [J].
MYGIND, N .
ALLERGY, 1993, 48 (07) :476-490
[7]   The rationale for use of topical corticosteroids in allergic rhinitis [J].
Mygind, N ;
Dahl, R .
CLINICAL AND EXPERIMENTAL ALLERGY, 1996, 26 :2-10
[8]   Challenge tests in nose and bronchi: Pharmacological modulation of rhinitis and asthma [J].
Mygind, N ;
Dahl, R .
CLINICAL AND EXPERIMENTAL ALLERGY, 1996, 26 :39-43
[9]  
NACLERIO RM, 1983, AM REV RESPIR DIS, V128, P597
[10]   NASAL IMMUNOTHERAPY TO PARIETARIA - EVIDENCE OF REDUCTION OF LOCAL ALLERGIC INFLAMMATION [J].
PASSALACQUA, G ;
ALBANO, M ;
RUFFONI, S ;
PRONZATO, C ;
RICCO, AM ;
DIBERARDINO, L ;
SCORDAMAGLIA, A ;
CANONICA, GW .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (02) :461-466